Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
filgotinib
Biotech
Ex-J&J science chief Stoffels lands at Galapagos to lead rebound
Paul Stoffels, one month after leaving the chief science role at J&J, is back to familiar territory: Belgian biotech Galapagos as it rebounds.
Kyle LaHucik
Jan 26, 2022 5:22pm
Galapagos CSO Wigerinck to leave after series of setbacks
Jun 23, 2021 5:30am
Gilead's $5B Galapagos black hole widens as pair cuts IPF drug
Feb 10, 2021 10:15am
Galapagos flunks phase 2, dashing hopes of $250M Gilead deal
Oct 16, 2020 8:00am
FDA rejects Gilead's would-be blockbuster filgotinib
Aug 19, 2020 4:22am
Gilead builds case for filgotinib in active psoriatic arthritis
Jun 8, 2020 8:10am
